Navigation Links
Glycotex, Inc. Releases Final Phase II Clinical Trials Results in the Clinicaltrials.gov Database and Announces the Results of the Mechanism of Action Study for its Product Candidate GLYC-101
Date:6/27/2011

l economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice and one-time events.  We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.


'/>"/>
SOURCE Glycotex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Glycotex, Inc. Expands Patent Portfolio in Advanced Wound Healing Indications
2. Ampio Pharmaceuticals, Inc. Releases Results From Phase III Clinical Trial of Zertane™ for the Treatment of Premature Ejaculation (PE), the Most Prevalent Form of Male Sexual Dysfunction
3. BGI Releases a Complete De Novo E. Coli O104 Genome Assembly and is Making Its Detection Kit Protocols and Synthesized Primers Freely Available to Worldwide Disease Control and Research Agencies
4. RF Technologies® Releases Code Alert® Quick Response® Wireless Call Solutions
5. Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software
6. SCAI Releases Position Statement on Public Reporting and Risk Adjustment In Cardiovascular Quality Improvement Programs
7. SCAI Releases First Report on Transradial Access for Angioplasty and Stenting
8. Mesa Labs Releases Major New DT Pro Software for Data Trace Data Loggers
9. Aethlon Medical Releases Shareholder Letter
10. Photonic Products Group, Inc. ("PPGI") Releases FY 2010 Financial Results
11. Applied Science Laboratories Releases Revolutionary Eye Tracking Analysis Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)...  Humberto C. Antunes,  Galderma  worldwide CEO, will receive a ... of Drugs in Dermatology (JDD) at the upcoming ... is January 17-20, 2014, at the Omni Orlando Resort at ChampionsGate ... The ODAC is a distinguished event that delivers a ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4
... The ophthalmic therapeutics company Xcovery Vision announced today that ... Ken Mandell, President and COO, will be speaking at ... Annual Meeting in Fort Lauderdale Florida, May 1-5, 2011. ... recounts his repeated success as founder of multiple ...
... Accuracy in radiation therapy demands careful targeting and ... Farber Center for Radiation Oncology , the first and ... is among the first treatment centers to adopt Elekta,s ... patient positioning system that enables clinicians to fine-tune ...
Cached Medicine Technology:Xcovery Vision Founders to Speak at ARVO 2011 2Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer 2
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... awarded one of 30 grants from the National Cancer ... Site in its new National Clinical Trials Network ... of investigators charged with distributing resources in a more ... system reflects recommendations from a 2010 Institute of ... goals:, Faster design, launch, and completion of ...
(Date:4/23/2014)... by Massachusetts General Hospital (MGH) investigators may lead to ... a serious medical problem use of fecal material ... the Clostridium difficile ( C. difficile ) ... the journal Clinical Infectious Diseases , the researchers ... donors unrelated to patients was as successful in curing ...
(Date:4/23/2014)... J. O,Shea, M.D., scientific director at the National Institute ... been named the 2014 recipient of the Ross Prize ... open-access journal Molecular Medicine . The award will ... Academy of Sciences in Manhattan, followed by scientific presentations ... part of the National Institutes of Health. , The ...
(Date:4/23/2014)... researchers have identified an important enzyme pathway that helps ... few chromosomes, a condition that has been directly linked ... professor of biochemistry, found that near the end of ... that ensures any breaks in DNA are fully repaired ... to daughter cells. This process helps safeguard against some ...
Breaking Medicine News(10 mins):Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
... of herbal products and medicines has the potential to reach ... the creation of exclusive export promotion zones (EPZ) across ... can be accelerated with the setting up of EPZs in ... rate of over 25 percent in countries like the US, ...
... as marijuana or ganja, can help in the treatment ... body tissues are attacked by its own immune system. ... University of Bonn, used tetrahydrocannabinol (THC), the active ingredient ... that it reduced skin allergies. ,However, the ...
... Today at the 61st Annual Meeting of the ... Cordis Corporation, announced the worldwide launch of the ... use in angioplasty procedures for patients with carotid ... a unique high-pressure expansion and low profile .014 ...
... better way to say "I love you" than showing your Dad ... come . This Father's Day, the American Diabetes Association (ADA) wants ... out by their doctor. ,More than 10 percent of all ... 2 diabetes, the most common form of the disease, can come ...
... number of suicide attempts among asylum seekers in Denmark has ... of despair," according to a study published Thursday . ... camps -- or 0.6 percent of the total -- tried ... by the Danish Association to Help Refugees said. ...
... for a new study has found that regular practice ... as well as the cognitive decline associated with ... practice, is centred on attentional and postural self-regulation and ... normal age-related decline of cerebral gray matter volume and ...
Cached Medicine News:Health News:Export of Herbal Products to Reach Rs.120 Billion by 2012: Study 2Health News:New Balloon Catheter Available Worldwide for Carotid and Renal Angioplasty 2Health News:Drag Dad to the Doctor This Father's Day 2
... Aestiva/5 Pendant anesthesia machine offers proven ... range with the SmartVent ventilator. However, ... superior ventilation. Enhancements in flexibility, ergonomics ... in anesthesia delivery., ,The Aestiva/5 ...
With its integrated design and superior build quality each Prima SP is custom built to meet your requirements....
... Tegagel hydrogel wound filler and ... are amorphous hydrogel dressings specially formulated ... that has been shown to enhance ... formula meets clinical needs for management ...
Features various cylinder sizes and a simple two-handed pumping mechanism....
Medicine Products: